Brazilian Pharmaceutical Exports to GCC up 73 Per Cent to Reach Over USD 7.4 Million in 2012
News May 13, 2013
Brazil exported USD 7.48 million worth of pharmaceutical products to the GCC in 2012, increasing by over 73 per cent compared to USD 4.31 million in 2011 according to figures released by the Arab Brazilian Chamber of Commerce (ABCC).
The Kingdom of Saudi Arabia and the UAE accounted for the biggest share of the Brazilian pharmaceutical exports at 57.02 per cent and 41.61 per cent, respectively.
The total pharmaceutical exports to KSA surged by 95.63 per cent in 2012 to reach USD 4.26 million from USD 2.18 million in 2011, while exports to the UAE were valued at USD 3.11 million, up 56.28 per cent from USD 1.99 million in 2011.
The top Brazilian pharmaceutical products that are exported to the region include antibiotics, dental products and vaccines for veterinary use.
The Arabian Gulf region ranks 44th among the top export destinations of Brazilian pharmaceutical products, but the Arab Brazilian Chamber of Commerce believes this presents a huge window of opportunity for Brazilian exporters to further expand their trade activities in the region.
Michel Alaby, General Secretary and CEO of Arab Brazilian Chamber of Commerce, said: “The dramatic increase in the value of pharmaceutical exports to the GCC clearly demonstrates the strategic importance of the Gulf region as a key trade partner of Brazil. KSA and the UAE, two of the biggest economies in the region, are particularly important and highly influential markets. Moreover, while the recent figures point to the robust growth performance of Brazilian pharmaceutical exports, it also underlines a huge potential to further expand our regional presence by opening new trade routes in other Gulf countries. Arab Brazilian Chamber of Commerce will therefore play an important role in connecting Brazilian exporters to key players in the GCC’s highly lucrative pharmaceutical market.”
Brazil has been a leading global supplier of pharmaceutical products with 10 of the world’s biggest pharmaceutical companies - Pfizer (United States), Novartis (Switzerland), Sanofi-Aventis (France), Roche (Switzerland), Medley (France), AstraZeneca (Anglo Swedish), EMS Sigma Pharma (Brazil), Eurofarma (Brazil), Aché (Brazil) and Merck (Germany) - having established manufacturing facilities in the country.
Brazil’s global exports of pharmaceutical products amounted to USD 2.98 billion in 2012 with Denmark, Venezuela, United States, Argentina and Mexico among its biggest global markets.
The Arab-Brazilian Chamber of Commerce has been established to consolidate and expand partnerships, generate opportunities and bring Arabs and Brazilians together.
It has been in operation for more than 50 years, playing an active role in boosting economic, cultural and tourism activities, and facilitating the flow of information between Arabs and Brazilians.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Molecule Prevents Common Cold Virus from Hijacking Human CellsNews
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.READ MORE
Improving Pharmaceuticals: Catalyst Specifically Tuned to Integrate Fluorine AtomsNews
In the race to create more potent and stable medicines, scientists know that adding fluorine can improve drug molecules. However, there is only one fluorination reaction known to occur in nature which is performed by complex and highly specialized enzymes that are difficult to replicate. Now, scientists have developed a new, streamlined molecule that can do the work of enzymes but be designed and controlled minutely.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018